Glenmark Pharma shares in focus as company swings back to profit in Q3

Glenmark Pharmaceuticals shares are expected to be in focus on Monday after the company posted a net profit of ₹348 crore for the December quarter, reversing a net loss of ₹351 crore in the same period last year.